DE60142632D1 - Heilung von wunden - Google Patents

Heilung von wunden

Info

Publication number
DE60142632D1
DE60142632D1 DE60142632T DE60142632T DE60142632D1 DE 60142632 D1 DE60142632 D1 DE 60142632D1 DE 60142632 T DE60142632 T DE 60142632T DE 60142632 T DE60142632 T DE 60142632T DE 60142632 D1 DE60142632 D1 DE 60142632D1
Authority
DE
Germany
Prior art keywords
healing
wounds
site
salve
topiramate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60142632T
Other languages
English (en)
Inventor
Nathan Andrew Shapira
Mary Catherine Lessig
Daniel John Driscoll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novodermix International Ltd
Original Assignee
Novodermix International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novodermix International Ltd filed Critical Novodermix International Ltd
Application granted granted Critical
Publication of DE60142632D1 publication Critical patent/DE60142632D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60142632T 2000-11-30 2001-11-30 Heilung von wunden Expired - Lifetime DE60142632D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25011300P 2000-11-30 2000-11-30
PCT/US2001/044923 WO2002043731A2 (en) 2000-11-30 2001-11-30 Treatments for neurogenetic disorders, impulse control disorders, and wound healing

Publications (1)

Publication Number Publication Date
DE60142632D1 true DE60142632D1 (de) 2010-09-02

Family

ID=22946345

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60142632T Expired - Lifetime DE60142632D1 (de) 2000-11-30 2001-11-30 Heilung von wunden

Country Status (7)

Country Link
US (3) US20020082222A1 (de)
EP (1) EP1345602B1 (de)
AT (1) ATE474572T1 (de)
AU (1) AU2002227052A1 (de)
CA (1) CA2430010A1 (de)
DE (1) DE60142632D1 (de)
WO (1) WO2002043731A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1345602B1 (de) * 2000-11-30 2010-07-21 Novodermix International Limited Heilung von wunden
US6462084B1 (en) * 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
WO2003097038A1 (en) * 2002-05-14 2003-11-27 Ralph Ryback Method for treating dermatoses and tissue damage
AU2003297639A1 (en) 2002-12-02 2004-06-23 University Of Florida Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases
US9744137B2 (en) 2006-08-31 2017-08-29 Supernus Pharmaceuticals, Inc. Topiramate compositions and methods of enhancing its bioavailability
EP2394643B1 (de) 2006-11-17 2015-09-02 Supernus Pharmaceuticals, Inc. Topiramat-Formulierungen mit verzögerter Freisetzung
CN102114002B (zh) * 2006-12-04 2016-05-11 苏佩努斯制药公司 托吡酯的增强的立即释放制剂
CA2727555C (en) 2008-06-12 2016-10-04 Global Kinetics Corporation Pty Ltd Detection of hypokinetic and/or hyperkinetic states
CN102256602A (zh) * 2008-10-21 2011-11-23 诺沃德米克斯国际有限公司 用于治疗上皮组织的组合物
KR20120092175A (ko) 2009-12-04 2012-08-20 죤 이. 그랜트 카테콜-0-메틸-트랜스퍼라제 저해제를 사용한 충동 제어 장애의 치료
TWI570472B (zh) * 2011-10-03 2017-02-11 三菱瓦斯化學股份有限公司 芳香族聚碳酸酯製偏光透鏡
TWI474831B (zh) 2012-09-14 2015-03-01 Univ Taipei Medical 免疫調節蛋白於促進傷口癒合或組織損傷治療的用途
US10292635B2 (en) * 2013-03-01 2019-05-21 Global Kinetics Pty Ltd System and method for assessing impulse control disorder
EP3113684B1 (de) 2014-03-03 2020-07-01 Global Kinetics Pty Ltd System zur beurteilung von bewegungssymptomen
JP2018520189A (ja) * 2015-07-17 2018-07-26 オービッド・セラピューティクス・インコーポレイテッドＯｖｉｄ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． ガボキサドールでの発達障害の処置方法
CA3184332A1 (en) * 2020-06-26 2021-12-30 Artur Manuel Cavaco Paulo Composition for hair follicle modulation, methods and uses thereof

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US892088A (en) * 1907-09-26 1908-06-30 William Rich Marine fire-indicating system and extinguisher.
US5705477A (en) * 1982-09-24 1998-01-06 The United States Of America As Represented By The Department Of Health And Human Services Compositions of transforming growth factor β(TGF-β) which promotes wound healing and methods for their use
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5571521A (en) * 1984-01-16 1996-11-05 Lasker; Sigmund E. Composition containing silver ammonium phenytoin complex and a phenytoin and use of said composition
US5856245A (en) * 1988-03-14 1999-01-05 Nextec Applications, Inc. Articles of barrier webs
US5632727A (en) * 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5692302A (en) * 1991-03-01 1997-12-02 Warner-Lambert Company Razor cartridges comprising wound healing compositions and methods for preparing and using same
US5646190A (en) * 1991-03-01 1997-07-08 Warner-Lambert Company Acne treating-wound healing compositions and methods for preparing and using same
US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
US5981606A (en) * 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
US5614561A (en) * 1991-03-01 1997-03-25 Warner-Lambert Company Antihistamine-wound healing compositions and methods for preparing and using same
US5658957A (en) * 1991-03-01 1997-08-19 Warner Lambert Company Immunostimulating wound healing compositions and method for preparing and using same
US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
US5662924A (en) * 1991-03-21 1997-09-02 Smith & Nephew Plc Wound dressing
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US5804213A (en) * 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
EP0612232B1 (de) * 1991-11-06 1999-05-06 Bioderm, Inc. 0kklusiver wundverband sowie vorrichtung zum anbringen
USRE36370E (en) * 1992-01-13 1999-11-02 Li; Shu-Tung Resorbable vascular wound dressings
US5376376A (en) * 1992-01-13 1994-12-27 Li; Shu-Tung Resorbable vascular wound dressings
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
US5525335A (en) * 1992-04-21 1996-06-11 Ajinomoto Co., Inc. Wound healing agent
EP0648113A4 (de) * 1992-04-23 1996-12-04 Berlex Lab Bioadhaesive feste mineraloelemulsion.
GB9212303D0 (en) * 1992-06-10 1992-07-22 Johnson & Johnson Medical Ltd Absorbent products
GB2272645B8 (en) * 1992-11-23 2010-02-10 Johnson & Johnson Medical Wound dressing
GB9225581D0 (en) * 1992-12-08 1993-01-27 Courtaulds Plc Wound dressings
US5902600A (en) * 1992-12-21 1999-05-11 Healthpoint, Ltd. Hydrogel polymer wound dressing
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
GB2275685B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Water soluble wound dressing materials
GB2275686B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Swellable wound dressing materials
US5960795A (en) * 1993-07-16 1999-10-05 Tecnol Medical Products, Inc. Wound covering device
JPH09503205A (ja) * 1993-09-24 1997-03-31 ザ ユニバーシティ オブ サザーン カリフォルニア 組織修復におけるアンギオテンシン▲ｉｉ▼類似体の使用
CA2172493C (en) * 1993-09-24 2003-09-16 Kathleen Elizabeth Rodgers Use of angiotensin iii and analogs thereof in tissue repair
US5955430A (en) * 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
US5603946A (en) * 1993-10-08 1997-02-18 Bristol-Myers Squibb Company Wound dressing
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5507775A (en) * 1994-01-21 1996-04-16 Progressive Surgical Products Inc. Tissue expansion and approximation device
JP3591837B2 (ja) * 1994-02-17 2004-11-24 ニューヨーク・ブラッド・センター・インコーポレイテッド フィブリン膠およびリポソームを含有する生物学的生体接着剤組成物、その製造方法および使用
AU1999995A (en) * 1994-04-08 1995-11-10 Atrix Laboratories, Inc. An adjunctive polymer system for use with medical device
US5522794A (en) * 1994-06-16 1996-06-04 Hercules Incorporated Method of treating human wounds
US5685834A (en) * 1994-07-29 1997-11-11 Barth; Alan H. Surgical dressing material
US5512041A (en) * 1994-10-07 1996-04-30 Scott Health Care Wound dressing for promoting moist wound healing
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
JPH10512780A (ja) * 1995-01-26 1998-12-08 イノベイティブ テクノロジーズ リミテッド 創傷用包帯
US6051249A (en) * 1995-01-27 2000-04-18 Coloplast A/S Dressing having a three-dimensional part and processes for the preparation of such a dressing
US5876743A (en) * 1995-03-21 1999-03-02 Den-Mat Corporation Biocompatible adhesion in tissue repair
US5578022A (en) * 1995-04-12 1996-11-26 Scherson; Daniel A. Oxygen producing bandage and method
US5690795A (en) * 1995-06-05 1997-11-25 Applied Materials, Inc. Screwless shield assembly for vacuum processing chambers
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
EP0830381A4 (de) * 1995-06-09 2000-11-22 William N Drohan Chitinhydrogele, herstellungsverfahren und anwendung
US6087549A (en) * 1997-09-22 2000-07-11 Argentum International Multilayer laminate wound dressing
US5892088A (en) * 1995-11-02 1999-04-06 Yukong Limited Sulfamate compound containing N-substituted carbamoyl group and method for preparing the same
KR970027051A (ko) * 1995-11-02 1997-06-24 조규향 카바모일기를 포함하는 신규한 설파메이트 화합물
GB9523253D0 (en) * 1995-11-14 1996-01-17 Mediscus Prod Ltd Portable wound treatment apparatus
AU725654B2 (en) * 1996-05-03 2000-10-19 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
US5968001A (en) * 1996-05-14 1999-10-19 Bristol-Myers Squibb Company Wound dressings with leak prevention seal
US6143037A (en) * 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
SK284266B6 (sk) * 1996-06-28 2004-12-01 Ortho-Mcneil Pharmaceutical, Inc. Antikonvulzívne deriváty vhodné na liečbu psoriázy
US5753693A (en) 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
HU226775B1 (en) * 1996-06-28 2009-09-28 Ortho Mcneil Pharm Inc The use of topiramate and its derivatives for preparation of pharmaceutical compositions useful for treating obesity or for weight loss
US5753694A (en) 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders
US6033684A (en) * 1996-08-28 2000-03-07 Jonor, Inc. Compositions and methods for wound management
US5807300A (en) * 1996-09-20 1998-09-15 Nix, Jr.; Frank H. Holder for wound dressing
US5897516A (en) * 1996-09-27 1999-04-27 Bristol-Myers Squibb Company Method of treating a wound by monitoring the swelling of a hydrocolloid layer in a wound dressing
EP0932400B1 (de) * 1996-10-08 2002-10-16 Ortho-McNeil Pharmaceutical, Inc. Antikonvulsive derivate zur behandlung von neuropathischem schmerz
US6025150A (en) * 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
US5807341A (en) * 1996-12-11 1998-09-15 Team Medical Llc Medical catheter dressing device
US5977428A (en) * 1996-12-20 1999-11-02 Procyte Corporation Absorbent hydrogel particles and use thereof in wound dressings
US5780048A (en) * 1997-03-20 1998-07-14 Lee; Chung Chih First aid bandage dressing system and method of application thereof
US5972332A (en) * 1997-04-16 1999-10-26 The Regents Of The University Of Michigan Wound treatment with keratinocytes on a solid support enclosed in a porous material
US5760006A (en) * 1997-06-23 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating psoriasis
US6136341A (en) * 1998-02-27 2000-10-24 Petito; George D. Collagen containing tissue adhesive
US5989577A (en) * 1998-03-02 1999-11-23 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
WO2000000130A1 (en) 1998-06-29 2000-01-06 The Procter & Gamble Company Liquid transport member for high flux rates against gravity
WO2000010610A2 (en) 1998-08-19 2000-03-02 Theramark Limited Drug targeting
WO2000023059A2 (en) * 1998-10-20 2000-04-27 Ortho-Mcneil Pharmaceutical, Inc. Use of anticonvulsant derivatives for treating alcohol dependency
NZ511881A (en) * 1998-11-17 2004-12-24 Ortho Mcneil Pharm Inc Anticonvulsant O-aklyl sulfamate derivatives useful in treating post traumatic stress disorder
CA2360677C (en) 1999-02-01 2005-07-05 Scott P. Hoopes Anticonvulsant derivatives useful in treating bulimia nervosa
BR0008791A (pt) * 1999-02-17 2005-04-05 Ortho Mcneil Pharm Inc Derivados anticonvulsivos, úteis no tratamento de tremor essencial
DK1158973T3 (da) * 1999-02-24 2005-05-30 Univ Cincinnati Anvendelse af sulfamatderivater til behandling af impulskontrolafvigelser
AU782344C (en) * 1999-04-08 2006-08-17 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
EP2305228B1 (de) * 1999-06-14 2015-05-06 Vivus, Inc. Kombinationstherapie zur Behandlung von Hyperlipidämie bei Fettleibigkeit
US6515117B2 (en) 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
EP1345602B1 (de) * 2000-11-30 2010-07-21 Novodermix International Limited Heilung von wunden
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
WO2003097038A1 (en) * 2002-05-14 2003-11-27 Ralph Ryback Method for treating dermatoses and tissue damage

Also Published As

Publication number Publication date
ATE474572T1 (de) 2010-08-15
US20080021094A1 (en) 2008-01-24
EP1345602B1 (de) 2010-07-21
CA2430010A1 (en) 2002-06-06
WO2002043731A2 (en) 2002-06-06
US20050101543A1 (en) 2005-05-12
EP1345602A2 (de) 2003-09-24
US8084491B2 (en) 2011-12-27
US20020082222A1 (en) 2002-06-27
WO2002043731A3 (en) 2003-02-20
WO2002043731B1 (en) 2003-04-03
AU2002227052A1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
ATE474572T1 (de) Heilung von wunden
DK1079807T3 (da) Anvendelse af præparater til tilförsel af antiseptiske midler og/eller midler, som fremmer heling af sår, til de nedre luftveje
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
HK1090843A1 (en) Pharmaceutical compositions for healing wounds
DK1227820T3 (da) Oligosaccharidaldonsyrer og topisk anvendelse deraf
DE60322436D1 (de) Verabreichung von capsaicinoiden
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
ES2250416T3 (es) Estimulante de secreciohn de hormona de crecimiento.
WO2005034883A3 (en) A method of healing skin wounds in mammals and a composition therefor
DE69902234D1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
BR0001291A (pt) Desfolhante
SE0004101D0 (sv) New use
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
DK1455849T3 (da) Sårbehandlingsanordning
SE0000303D0 (sv) Novel compounds
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
SE0301885D0 (sv) New use IV
SE0301884D0 (sv) New use III
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
FR2853245B1 (fr) Utilisation du quinquina pour la preparation d'un medicament stimulant l'angiogenese
MY143194A (en) Topical pharmaceutical compositions for healing wounds
ITPD920102A1 (it) Composizione farmaceutica utile per trattare malattie gastroenteriche, ferite e ustioni e come agente emostatico
ATE218366T1 (de) Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilung